Published in Curr Eye Res on January 01, 2008
Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res (2010) 1.33
Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol (2012) 1.21
Corneal penetration of topical and subconjunctival bevacizumab. Invest Ophthalmol Vis Sci (2011) 1.07
Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab. J Ophthalmol (2014) 0.94
Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis. Graefes Arch Clin Exp Ophthalmol (2009) 0.93
[Antiangiogenic therapy for pterygium recurrence]. Ophthalmologe (2009) 0.88
Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization. Mol Vis (2009) 0.86
Topically administered bevacizumab had longer standing anti-angiogenic effect than subconjunctivally injected bevacizumab in rat corneal neovacularization. Int J Ophthalmol (2013) 0.85
Subconjunctival bevacizumab for primary pterygium excision; a randomized clinical trial. J Ophthalmic Vis Res (2014) 0.83
Subconjunctival bevacizumab in the impending recurrent pterygia. Int Ophthalmol (2013) 0.80
The effect of bevacizumab versus ranibizumab in the treatment of corneal neovascularization: a preliminary study. Korean J Ophthalmol (2013) 0.79
Delayed corneal epithelial healing after intravitreal bevacizumab: a clinical and experimental study. J Ophthalmic Vis Res (2011) 0.78
Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization. PLoS One (2014) 0.78
Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up. J Ocul Pharmacol Ther (2014) 0.78
Correlation between NGF/TrkA and microvascular density in human pterygium. Int J Exp Pathol (2009) 0.78
Corneal endothelial safety following subconjunctival and intrastromal injection of bevacizumab for corneal neovascularization. Int Ophthalmol (2013) 0.77
Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium. Clin Ophthalmol (2013) 0.77
Repeated bevacizumab injections versus mitomycin C in rotational conjunctival flap for prevention of pterygium recurrence. Indian J Ophthalmol (2014) 0.77
[Pterygium. Etiology, clinical aspects and novel adjuvant therapies]. Ophthalmologe (2010) 0.76
Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13. PLoS One (2017) 0.75
Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting? Int J Ophthalmol (2014) 0.75
Oral doxycycline reduces pterygium lesions; results from a double blind, randomized, placebo controlled clinical trial. PLoS One (2012) 0.75
Evaluating the safety of intracameral bevacizumab application using oxidative stress and apoptotic parameters in corneal tissue. Int J Ophthalmol (2015) 0.75
Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization. Int J Nanomedicine (2017) 0.75
VSX1: a gene for posterior polymorphous dystrophy and keratoconus. Hum Mol Genet (2002) 2.49
Comparison of posterior lamellar keratoplasty techniques to penetrating keratoplasty. Ophthalmology (2008) 1.79
Busin Guide vs Forceps for the Insertion of the Donor Lenticule in Descemet Stripping Automated Endothelial Keratoplasty. Am J Ophthalmol (2008) 1.60
The effect of mitomycin C on corneal endothelium in pterygium surgery. Am J Ophthalmol (2008) 1.55
Fibrin glue for opposing wound edges in "Top Hat" penetrating keratoplasty: a laboratory study. Cornea (2007) 1.50
Retrospective contralateral study comparing descemet stripping automated endothelial keratoplasty with penetrating keratoplasty. Cornea (2009) 1.50
Associated morbidity of blepharitis. Ophthalmology (2011) 1.45
Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome. Br J Ophthalmol (2013) 1.38
Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial. Can J Ophthalmol (2011) 1.28
Subconjunctival bevacizumab injection for corneal neovascularization. Cornea (2008) 1.16
Flap thickness using the moria one use-plus and moria m2 microkeratomes. J Refract Surg (2011) 1.09
Comparison of three different techniques of corneal transplantation for keratoconus. Am J Ophthalmol (2008) 1.07
Retracted Cionni endocapsular ring implantation in Marfan's Syndrome. Br J Ophthalmol (2007) 1.04
IntraLase-enabled astigmatic keratotomy for postkeratoplasty astigmatism. Am J Ophthalmol (2008) 1.03
Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjögren's syndrome. Can J Ophthalmol (2004) 1.02
Femtosecond laser-assisted penetrating keratoplasty: stability evaluation of different wound configurations. Cornea (2008) 0.96
Birth order and myopia. Ophthalmic Epidemiol (2013) 0.94
Outcome of lamellar keratoplasty for limbal dermoids in children. J AAPOS (2002) 0.93
Long-term effects of mitomycin C in pterygium surgery on scleral thickness and the conjunctival epithelium. Ophthalmology (2004) 0.91
Late traumatic displacement of laser in situ keratomileusis flaps. Cornea (2003) 0.91
IntraLase-enabled astigmatic keratotomy for post-keratoplasty astigmatism: on-axis vector analysis. Ophthalmology (2010) 0.90
The association of keratoconus with immune disorders. Cornea (2010) 0.90
Topographic patterns in refractive surgery candidates. Cornea (2004) 0.89
Effective treatment of ligneous conjunctivitis with topical plasminogen. Am J Ophthalmol (2002) 0.88
Deep lamellar endothelial keratoplasty: up to 5-year follow-up. Ophthalmology (2010) 0.87
Suture-assisted vs forceps-assisted insertion of the donor lenticula during Descemet stripping automated endothelial keratoplasty. Am J Ophthalmol (2008) 0.86
Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye. Optom Vis Sci (2008) 0.86
Descemet's stripping with endothelial keratoplasty in iridocorneal endothelial syndrome. Ophthalmic Surg Lasers Imaging (2008) 0.86
Descemet's stripping automated endothelial keratoplasty for posterior polymorphous corneal dystrophy in an 8-month-old boy. J AAPOS (2013) 0.85
Statins do not decrease the risk for wet age-related macular degeneration. Curr Eye Res (2009) 0.84
Changes in anterior segment parameters after insertion of Ex-PRESS miniature glaucoma implant. J Glaucoma (2013) 0.84
The efficacy of oral ivermectin for the treatment of chronic blepharitis in patients tested positive for Demodex spp. Br J Ophthalmol (2011) 0.84
Temporal and seasonal trends in Acanthamoeba keratitis. Cornea (2009) 0.84
Evolving surgical techniques of and indications for corneal transplantation in Ontario: 2000 - 2012. Can J Ophthalmol (2013) 0.83
Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization. Cornea (2008) 0.83
Changes in corneal curvatures and anterior segment parameters after descemet stripping automated endothelial keratoplasty. Curr Eye Res (2010) 0.82
Anterior segment uses of bevacizumab. Curr Opin Ophthalmol (2012) 0.82
Rose bengal staining of the temporal conjunctiva differentiates Sjögren's syndrome from keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci (2010) 0.82
Associated morbidity of chalazia. Cornea (2011) 0.81
Factors Predicting the Need for Retreatment After Laser Refractive Surgery. Cornea (2016) 0.81
Prescription of ocular beta-blockers in patients with obstructive pulmonary disease: Does a central electronic medical record make a difference? Clin Drug Investig (2006) 0.79
Prognostic factors in Acanthamoeba keratitis. Can J Ophthalmol (2012) 0.79
Long-term adherence to antihypertensive therapy: a survey in four primary care clinics. Expert Opin Pharmacother (2008) 0.79
The effect of successful rebubbling after descemet stripping automated endothelial keratoplasty on endothelial cell counts. Cornea (2010) 0.79
The dynamics of serum tumor markers in predicting metastatic uveal melanoma (part 1). Anticancer Res (2011) 0.79
Bilateral simultaneous Achromobacter xylosoxidans keratitis following penetrating keratoplasty. J Cataract Refract Surg (2006) 0.78
Prevalence of Epilepsy among Cataract Patients. Curr Eye Res (2010) 0.78
Femtosecond LASIK combined with astigmatic keratotomy for the correction of refractive errors after penetrating keratoplasty. Ophthalmic Surg Lasers Imaging (2010) 0.78
High prevalence of myasthenia gravis among rural adult populations. J Clin Neuromuscul Dis (2014) 0.78
First 100: learning curve for Descemet stripping automated endothelial keratoplasty. Eur J Ophthalmol (2013) 0.78
The burst of mitochondrial diseases: neurons and calcium. Isr Med Assoc J (2004) 0.77
Trends in liver function tests: a comparison with serum tumor markers in metastatic uveal melanoma (part 2). Anticancer Res (2011) 0.77
Comparison of Three Epithelial Removal Techniques in PRK: Mechanical, Alcohol-assisted, and Transepithelial Laser. J Refract Surg (2015) 0.77
Are cataracts associated with osteoporosis? Clin Ophthalmol (2013) 0.77
The effect of riboflavin-ultraviolet A-induced collagen cross-linking on intraocular pressure measurement: an experimental study. Br J Ophthalmol (2012) 0.77
Extensive versus limited pterygium excision with conjunctival autograft: outcomes and recurrence rates. Curr Eye Res (2008) 0.77
Accuracy of Scheimpflug Holladay equivalent keratometry readings after corneal refractive surgery in the absence of clinical history. Ophthalmic Res (2014) 0.77
Detachment of subfoveal choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol (2002) 0.77
Factor analysis of the clinical characteristics of primary Sjogren syndrome. Optom Vis Sci (2010) 0.77
Non-penetrating deep sclerectomy for glaucoma surgery using the femtosecond laser: a laboratory model. Br J Ophthalmol (2007) 0.75
Paediatric intraocular lenses: the power to choose? Clin Experiment Ophthalmol (2007) 0.75
Femtosecond laser top hat penetrating keratoplasty: wound burst pressures of incomplete cuts. Arch Ophthalmol (2008) 0.75
The effect of laser in situ keratomileusis on low contrast vision. J Refract Surg (2004) 0.75
Combined penetrating keratoplasty and implantation of iris prosthesis intraocular lenses after ocular trauma. J Cataract Refract Surg (2011) 0.75
Predicting Refractive Surgery Outcome: Machine Learning Approach With Big Data. J Refract Surg (2017) 0.75
Estimating intraocular pressure using a glass rod. Ann Ophthalmol (Skokie) (2006) 0.75
Manual top hat wound configuration for penetrating keratoplasty. Cornea (2008) 0.75
Urgent referrals to a specialist by family physicians--is the "urgency" real: a prospective study. Eur J Gen Pract (2007) 0.75
Scleral and conjunctival pigmentation following minocycline therapy. Can J Ophthalmol (2007) 0.75
Alcohol- vs hypertonic saline-assisted laser-assisted subepithelial keratectomy. Arch Ophthalmol (2005) 0.75
Five-millimeter-incision deep lamellar endothelial keratoplasty: one-year results. Cornea (2007) 0.75
Effect of Anisometropia on the Predictability and Accuracy of Refractive Surgery. Cornea (2016) 0.75
The use of ophthalmic viscosurgical devices during donor's corneal harvesting. Curr Eye Res (2013) 0.75
Induced De Novo Astigmatism After Hyperopic LASIK Versus Myopic LASIK Surgery in Nonastigmatic Eyes. Cornea (2017) 0.75